中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版)

徐兵河; 邵志敏; 胡夕春

doi:10.19401/j.cnki.1007-3639.2016.08.012

您当前的位置：

首页 >

文章列表页 >

中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版)

更新时间：2025-12-31

- 中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版)
- China Oncology Vol. 26, Issue 8, Pages: 712-720(2016)
- 作者机构：
  
  1. 中国医学科学院肿瘤医院肿瘤内科,北京,100021
  2. 复旦大学附属肿瘤医院乳腺外科，复旦大学上海医学院肿瘤学系,上海,200032
  3. 复旦大学附属肿瘤医院肿瘤内科，复旦大学上海医学院肿瘤学系,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2016.08.012
  CLC：
- Published Online：19 October 2016，
  
  Published：19 October 2016
- 稿件说明：
移动端阅览
徐兵河,邵志敏,胡夕春,等. 中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版)[J]. 中国癌症杂志, 2016, 26(8): 712-720.

徐兵河, 邵志敏, 胡夕春. 中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版)[J]. China Oncology, 2016, 26(8): 712-720.
徐兵河,邵志敏,胡夕春,等. 中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版)[J]. 中国癌症杂志, 2016, 26(8): 712-720. DOI： 10.19401/j.cnki.1007-3639.2016.08.012.

徐兵河, 邵志敏, 胡夕春. 中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版)[J]. China Oncology, 2016, 26(8): 712-720. DOI： 10.19401/j.cnki.1007-3639.2016.08.012.

摘要

Abstract

关键词

Keywords

references

Views

3465

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2021 CACA-CBCS

Research advances in estrogen receptor low positive early breast cancer

Clinical consideration of two key questions in assessing menopausal status of female breast cancer patients

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition)

Factors-associated with short-term effect and long-term survival of ovarian function suppression in estrogen receptor positive breast cancer: a retrospective analysis

Related Author

Committee of Breast Cancer Society Chinese Anti-Cancer Association,

Yizi JIN

Mingxi LIN

Cheng ZENG

Qing GUO

Jian ZHANG

China Anti-Cancer Association Committee of Breast Cancer Society,

Yiming LIU

Related Institution

Department of Medical Oncology, Fudan University Shanghai Cancer Center; Phase Ⅰ Clinical Trial Center, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

复旦大学附属眼耳鼻喉医院眼科

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

AI问答

⁰